Celltrion
068270.KS
#765
Rank
โ‚น2.274 T
Marketcap
โ‚น10,569
Share price
0.80%
Change (1 day)
-5.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น260.30. In 2022 the company made an earnings per share (EPS) of โ‚น253.40 a decrease over its 2021 EPS that were of โ‚น301.10.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-3.21%
2022โ‚น253.40-15.84%
2021โ‚น301.1012.77%
2020โ‚น267.0070.79%
2019โ‚น156.3315.63%
2018โ‚น135.20-33.13%
2017โ‚น202.20141.17%
2016โ‚น83.848.28%
2015โ‚น77.4311.28%
2014โ‚น69.5816.37%
2013โ‚น59.79-67.42%
2012โ‚น183.5584.22%
2011โ‚น99.6462.13%
2010โ‚น61.4680.61%
2009โ‚น34.03-559.63%
2008-โ‚น7.40-123.16%
2007โ‚น31.96